Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
17.24
+0.42 (2.50%)
At close: Jul 24, 2026, 4:00 PM EDT
17.02
-0.22 (-1.25%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,029 employees as of March 31, 2026. The number of employees decreased by 426 or -0.90% compared to the previous year.
Employees
47,029
Change (1Y)
-426
Growth (1Y)
-0.90%
Revenue / Employee
$602,542
Profits / Employee
-$20,379
Market Cap
55.09B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 47,029 | -426 | -0.90% |
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | 47,099 | -396 | -0.83% |
| Mar 31, 2020 | 47,495 | -2,083 | -4.20% |
| Mar 31, 2019 | 49,578 | 22,348 | 82.07% |
| Mar 31, 2018 | 27,230 | -2,670 | -8.93% |
| Mar 31, 2017 | 29,900 | -1,268 | -4.07% |
| Mar 31, 2016 | 31,168 | -160 | -0.51% |
| Mar 31, 2015 | 31,328 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
TAK News
- 4 days ago - Takeda dengue vaccine receives marketing authorization from India DCGI - TheFly
- 5 days ago - Takeda's QDENGA becomes first dengue vaccine approved in India - Reuters
- 9 days ago - Takeda's Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies - Business Wire
- 12 days ago - Takeda Pharmaceutical (TAK) Launches Plasma Ecosystem Initiative in Indonesia - GuruFocus
- 12 days ago - Takeda, the Indoensian Government announce collaboration - TheFly
- 12 days ago - Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products - Business Wire
- 22 days ago - Takeda Pharmaceutical Co Ltd (TAK) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
- 23 days ago - Insilico Medicine Announces Strategic AI Drug Discovery Collaboration With Takeda - Nasdaq